Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HER2 Expression”

172 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 172 results

Large-scale testing (Phase 3)Looking for participantsNCT07315750
What this trial is testing

Disitamab Vedotin Combined With Trastuzumab and Tislelizumab Versus Chemotherapy Combined With Trastuzumab With or Without Pembrolizumab in HER2-high Expression Advanced Gastric or Gastroesophageal Junction Adenocarcinoma.

Who this might be right for
Gastric Carcinoma
RemeGen Co., Ltd. 555
Testing effectiveness (Phase 2)Ended earlyNCT01531764
What this trial is testing

BIBW 2992 (Afatinib) and Vinorelbine

Who this might be right for
Carcinoma Breast Stage IV
University of Magdeburg 2
Testing effectiveness (Phase 2)UnknownNCT04965519
What this trial is testing

RC48-ADC for the Treatment of HER2-expressing Gynecological Malignancies

Who this might be right for
Gynecological Malignancy
RemeGen Co., Ltd. 120
Post-approval studies (Phase 4)Looking for participantsNCT07195344
What this trial is testing

Study Aiming to Compare the Plasma Exposure of the Payload (Free-DXd) in Patients Treated by T-DXd for Locally Advanced or Metastatic Breast Cancer According to Their BMI.

Who this might be right for
Locally Advanced or Metastatic Breast Cancers
Institut Claudius Regaud 210
Testing effectiveness (Phase 2)Ended earlyNCT01207102
What this trial is testing

Study Of Abraxane® And Carboplatin As First-Line Treatment For Triple Negative Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Duke University 10
Testing effectiveness (Phase 2)UnknownNCT06178601
What this trial is testing

RC48-ADC Combined With Cadonilimab（AK104）in the Treatment of HER2-expression Locally Advanced or Metastatic Urothelial Carcinoma

Who this might be right for
Urothelial Carcinoma
Shanxi Province Cancer Hospital 36
Testing effectiveness (Phase 2)Looking for participantsNCT06131450
What this trial is testing

BL-M07D1 in Patients With HER2-expressing Recurrent or Metastatic Gynecologic Malignancies

Who this might be right for
Gynecological Malignancies
Sichuan Baili Pharmaceutical Co., Ltd. 138
Not applicableLooking for participantsNCT06289517
What this trial is testing

PET Imaging of 68Ga-Her2-affibody in Tumors with High Her2 Expression

Who this might be right for
Neoplasms
Peking University First Hospital 30
Not applicableUnknownNCT02852096
What this trial is testing

Assessing Her2/Neu Expression in Gastric Cancer With Dual or Multiple Tumor Tissue Paraffin Blocks

Who this might be right for
Gastric CancerHER-2
Shanghai Zhongshan Hospital 600
Testing effectiveness (Phase 2)UnknownNCT06000033
What this trial is testing

Study of Disitamab Vedotin and Anlotinib in Patients With HR-Negative, HER2-Low-Expressing Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Qilu Hospital of Shandong University 35
Testing effectiveness (Phase 2)UnknownNCT05338957
What this trial is testing

MRG002 in the Treatment of Patients With HER2-expressed Advanced Malignant Solid Tumors.

Who this might be right for
Advanced Malignant Solid Tumors
Shanghai Miracogen Inc. 30
Not applicableStudy completedNCT05217381
What this trial is testing

Real-World Data of Clinicopathological Characteristics and Management of Breast Cancer Patients According to HER2 Status

Who this might be right for
Early Breast CancerMetastatic Breast CancerLocally Advanced Breast Cancer
MedSIR 18,533
Early research (Phase 1)Looking for participantsNCT06500052
What this trial is testing

BL-M17D1 in Patients With Locally Advanced or Metastatic HER2 Positive/Lower Expression Gastrointestinal Cancer and Other Solid Tumors

Who this might be right for
Esophageal CancerGastric CancerPancreatic Cancer+2 more
Sichuan Baili Pharmaceutical Co., Ltd. 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT06198751
What this trial is testing

Neoadjuvant Treatment With TQB2102 for Injection for Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer

Who this might be right for
Breast Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 104
Not applicableUnknownNCT06146114
What this trial is testing

Single Center Registration Study on HER2 Expression and Clinical Pathological Characteristics in Prostate Cancer

Who this might be right for
HER2 Expression and Clinical Pathological Characteristics in Prostate Cancer
Qilu Hospital of Shandong University 100
Not applicableUnknownNCT04365790
What this trial is testing

Investigation of Gene Mutations in Patients With Triple-negative and Patients With HER2+ Breast Cancer Adenocarcinoma

Who this might be right for
Breast Cancer
Hellenic Cooperative Oncology Group 500
Not applicableStudy completedNCT00071383
What this trial is testing

Analysis of Brain Metastasis in Patients With Breast Cancer, With and Without Over-Expression of HER-2

Who this might be right for
Breast Neoplasms
National Institute of Neurological Disorders and Stroke (NINDS) 78
Early research (Phase 1)Looking for participantsNCT05940896
What this trial is testing

RC48-ADC Combined With Radiotherapy in the Treatment of Locally Advanced Solid Tumors With HER2 Expression

Who this might be right for
Solid Tumor
RemeGen Co., Ltd. 24
Testing effectiveness (Phase 2)Looking for participantsNCT07817082
What this trial is testing

Phase II Study of SHR-A1811 for Ultra-Low HER2 Advanced Breast Cancer

Who this might be right for
Advanced Breast Cancer With Ultra-Low HER2 Expression
Tianjin Medical University Cancer Institute and Hospital 30
Testing effectiveness (Phase 2)Study completedNCT01858116
What this trial is testing

PET Study of Breast Cancer Patients Using [68Ga]ABY-025

Who this might be right for
Breast Cancer
Biomedical Radiation Sciences 16
Next Page